Sign in
TerminatedNo phase

Nurse Intervention Trial

Key facts

Who runs it
Norwegian University of Science and Technology
Where
Norway1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
147 people enrolled
Started
21 Apr 2023
Ended
31 Jan 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Telephone by nurse
Record updated
13 April 2026
Why it stopped
Based on ethical considerations arising from the interim analyses, the study was terminated before the planned sample size of 400 participants was reached

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • One of the following headache diagnoses based on the International Classification of Headache Disorders, third edition (ICDH3): G44.2 Chronic tension-type headache and/or G43 Episodic and chronic migraine, G44.0 Episodic and chronic cluster headache, G44.8 Hemicrania Continua
  • Indication for preventive medication where there is at least one alternative with the need for follow-up assessment of effectiveness

Who cannot take part

  • Treatment with Onabotulinumtoxin A or Calcitonin-gene-related Peptide (CGRP) inhibitors given with three months intervals
  • Need treatment of other comorbid conditions requiring follow-up in specialized healthcare
  • Uncertain headache diagnosis
  • Need further investigation after the initial consultation
  • Lack of understanding of information provided in Norwegian, both verbally and in writing
  • Inability to keep a digital headache diary

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized open-label prospective study focus on headache patients initiating preventive treatment, where the treating physician identifies a need for follow-up visits in specialized healthcare. The study will clarify whether the implementation (compliance) and overall satisfaction of the patient are better with follow-up by a headache nurse compared to standard follow-up. Patients with signed written consent will be randomised to either group a: Telephone calls from nurse after two and 6 week or B. Patient-initiated follow-up by their general practitioner.

The 2 groups in the trial

  • Telephone by nurseExisting treatment, for comparison

    The headache patients will be contacted by nurse by phone after approximately 2 week and 6 week after start of preventive medical treatment. The patient will have a follow-up visit by neurologist after 3 months.

  • Patient-initiated follow-upNo study treatment, for comparison

    The headache patient contact their general practitioner (GP) and/or the neurologist by a study-specific email if they have questions regarding the preventive medical treatment

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Nurse Intervention Trial: The Evaluation of Usefulness of a Headache Nurse
Record updated
13 April 2026